MIRA PHARMACEUTICALS, INC. Cash And Cash Equivalents At Carrying Value

Quick Answer

MIRA PHARMACEUTICALS, INC. reported Cash And Cash Equivalents At Carrying Value of $6.35 million for the year ending 2025.

MIRA PHARMACEUTICALS, INC. showed an increase of +124.0% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
This data is from MIRA PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
XBRL data for this metric is available from 2024 to 2025 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
Historical annual values: Fiscal year 2025: $6.35 million | Fiscal year 2024: $2.83 million.
Data sourced from SEC EDGAR public filings as of June 24, 2026.

Last verified: June 24, 2026